DRUG.ASX
Betashares Global Healthcare ETF - Currency Hedged
https://www.marketindex.com.au/asx/drug/financials
Annual Financial Summary
Print Financials
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
N/A
N/A
Profitability
NPAT ($)
1,565,000
15,131,000
-
-
-
-
NPAT Margin
--
--
-
-
-
-
Abnormals ($)
-
-
-
-
-
-
NPAT before Abnormals ($)
1,565,000
15,131,000
-
-
-
-
Return on Equity (ROE)
0.99%
14.04%
-
-
-
-
Return on Assets (ROA)
0.95%
13.15%
-
-
-
-
Valuation
PE Ratio
101.21
7.50
-
-
-
-
PE Relative to Market
625.5%
57.1%
-
-
-
-
Price to Book
1.00
1.05
-
-
-
-
Price to Cash Flow
144.36
10.71
-
-
-
-
Shares Outstanding (M)
21.09
14.62
-
-
-
-
Market Cap ($M)
$158.35
$113.44
-
-
-
-
Enterprise Value ($M)
$157.96
$113.28
-
-
-
-
Performance
Total Shareholder Return
1.5%
20.8%
-
-
-
-
Relative to Market
8.9%
-9.4%
-
-
-
-
Per Share
Earnings (EPS Adjusted)
7.42
103.50
-
-
-
-
Earnings (with Abnormals)
7.42
103.50
-
-
-
-
Cash Flow
(209.40)
(345.80)
-
-
-
-
Cash
0.02
0.01
-
-
-
-
Net Tangible Assets
7.53
7.37
-
-
-
-
Book Value
7.53
7.37
-
-
-
-
Share Price
$7.51
$7.76
-
-
-
-
Liquidity
Quick Ratio
9.79
0.08
-
-
-
-
Current Ratio
9.79
0.08
-
-
-
-
Efficiency
Asset Turnover
0.00
0.00
-
-
-
-
Inventory Turnover
-
-
-
-
-
-
Working Capital Turnover
0.00
0.00
-
-
-
-
Dividends
DPS (c)
1.92
36.64
-
-
-
-
Dividend yield
-
4.72%
-
-
-
-
Franking
-
-
-
-
-
-
Gross DPS (c)
1.92
36.64
-
-
-
-
Gross Dividend Yield
-
4.72%
-
-
-
-
Payout Ratio
26%
35%
-
-
-
-
Member Content
Source:
Annual Financial Income Statement
Print Financials
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
N/A
N/A
Revenue from Operations
Investment Income
2,499,000
1,638,000
-
-
-
-
Other Income
(35,000)
13,985,000
-
-
-
-
Expenses
(899,000)
(492,000)
-
-
-
-
Profit / Loss before income tax
1,565,000
15,131,000
-
-
-
-
Tax Expense
-
-
-
-
-
-
NPAT before Abnormals
1,565,000
15,131,000
-
-
-
-
Abnormals
-
-
-
-
-
-
Abnormals Tax
-
-
-
-
-
-
Net Abnormals
-
-
-
-
-
-
Outside Equity
-
-
-
-
-
-
Preference Dividends
-
-
-
-
-
-
Reported NPAT after Abnormals
1,565,000
15,131,000
-
-
-
-
EQUITY
Share End
21,085,000
14,619,000
-
-
-
-
Share Weighted
21,085,000
14,619,000
-
-
-
-
Ordinary Dividends
(401,000)
-
-
-
-
-
EPS Adjusted
74,200
1,035,000
-
-
-
-
EPS after Abs
74,223
1,035,023
-
-
-
-
Equity Profit / Loss
-
-
-
-
-
-
Member Content
Source:
Annual Financial Balance Sheet
Print Financials
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
N/A
N/A
CURRENT ASSETS
Cash and Cash Equivalents
0.39
0.17
-
-
-
-
Receivables
0.37
0.23
-
-
-
-
Investments
-
-
-
-
-
-
Other Current Assets
-
-
-
-
-
-
Total Current Assets
0.76
0.4
-
-
-
-
NON-CURRENT ASSETS
Investments
164.34
114.71
-
-
-
-
Property
-
-
-
-
-
-
Other Non-Current Assets
-
-
-
-
-
-
Total Non-Current Assets
164.34
114.71
-
-
-
-
TOTAL ASSETS
165.11
115.11
-
-
-
-
CURRENT LIABILITIES
Creditors
0.08
0.06
-
-
-
-
Provisions
-
5.11
-
-
-
-
Other Liabilities
-
-
-
-
-
-
TOTAL CURRENT LIABILITIES
0.08
5.17
-
-
-
-
NON-CURRENT LIABILITIES
Borrowings
-
-
-
-
-
-
Deferred Tax
-
-
-
-
-
-
Other Non-Current Liabilities
6.22
2.18
-
-
-
-
TOTAL NON-CURRENT LIABILITIES
6.22
2.18
-
-
-
-
TOTAL LIABILITIES
6.3
7.35
-
-
-
-
NET ASSETS
171.41
122.46
-
-
-
-
Total Equity Attr. to Holders
158.81
107.76
-
-
-
-
Outside Equity
-
-
-
-
-
-
TOTAL EQUITY
158.81
107.76
-
-
-
-
Member Content
Source:
Annual Financial Cash Flow
Print Financials
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
N/A
N/A
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
58
23.74
-
-
-
-
Payments
(103.68)
(75.41)
-
-
-
-
Funds from Operations
-
-
-
-
-
-
Dividends Received
2.48
1.55
-
-
-
-
Interest Received
-
-
-
-
-
-
Interest Paid
-
-
-
-
-
-
Tax Paid
-
-
-
-
-
-
Other Operating Cash
(0.96)
(0.44)
-
-
-
-
NET CASH FROM OPERATING ACTIVITIES
(44.16)
(50.55)
-
-
-
-
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
-
-
-
-
-
-
Payments
-
-
-
-
-
-
PP&E
-
-
-
-
-
-
Proceeds PP&E
-
-
-
-
-
-
Purchase Subsidiary
-
-
-
-
-
-
Proceeds Subsidiary
-
-
-
-
-
-
Loans Granted
-
-
-
-
-
-
Loans Repaid
-
-
-
-
-
-
Other Investing Cash
-
-
-
-
-
-
NET CASH FROM INVESTING ACTIVITIES
-
-
-
-
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
53.82
51.15
-
-
-
-
Proceeds from Borrowings
-
-
-
-
-
-
Borrowings
-
-
-
-
-
-
Dividends Paid
(5.02)
(0.47)
-
-
-
-
Other Financing Cash
(4.42)
-
-
-
-
-
NET CASH FROM FINANCING ACTIVITIES
44.38
50.67
-
-
-
-
NET CHANGE IN CASH
0.22
0.12
-
-
-
-
CASH AT START
0.17
0.04
-
-
-
-
Exchange Rate Adjustment
0.01
-
-
-
-
-
Other Cash Adjustment
-
-
-
-
-
-
CASH AT END
0.39
0.17
-
-
-
-
Member Content
Source: